Recursion Enhances its Leadership Team and Deepens Focus on Neuroscience with Three Senior Appointments
/PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery,...
Source: prnewswire.com